This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1984 Oct;18(4):650-2.

doi: 10.1111/j.1365-2125.1984.tb02524.x.

Measurement of antipyrine half-life from urinary drug concentrations

G Taylor, T F Blaschke

PMID: 6487512
PMCID: PMC1463628
DOI: 10.1111/j.1365-2125.1984.tb02524.x

Measurement of antipyrine half-life from urinary drug concentrations

G Taylor et al. Br J Clin Pharmacol. 1984 Oct.

. 1984 Oct;18(4):650-2.

doi: 10.1111/j.1365-2125.1984.tb02524.x.

Authors

G Taylor, T F Blaschke

PMID: 6487512
PMCID: PMC1463628
DOI: 10.1111/j.1365-2125.1984.tb02524.x

No abstract available

PubMed Disclaimer

Similar articles

Serial measurements of plasma half-lives and urinary excretion of antipyrine in low-birth-weight infants.
Murdock AI, Thorgeirsson SS, Rossiger H, Davies DS. Murdock AI, et al. Biol Neonate. 1975;27(5-6):289-301. doi: 10.1159/000240786. Biol Neonate. 1975. PMID: 1174600
The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D, Blevins R, Kerner N, Rubenfire M, Edwards DJ. Bach D, et al. Br J Clin Pharmacol. 1986 Jun;21(6):655-9. doi: 10.1111/j.1365-2125.1986.tb05230.x. Br J Clin Pharmacol. 1986. PMID: 3741715 Free PMC article.
Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
Breckenridge A, Burke CW, Davies DS, Orme ML. Breckenridge A, et al. Br J Pharmacol. 1973 Feb;47(2):434-6. doi: 10.1111/j.1476-5381.1973.tb08344.x. Br J Pharmacol. 1973. PMID: 4722054 Free PMC article.
Antipyrine metabolism in coke oven workers.
Arvela P, Pelkonen O, Pyy L, Sotaniemi E, Vähäkangas K, Yrjänheikki E. Arvela P, et al. Arch Toxicol Suppl. 1991;14:201-4. doi: 10.1007/978-3-642-74936-0_41. Arch Toxicol Suppl. 1991. PMID: 1805733 No abstract available.
Factors influencing antipyrine elimination.
Stevenson IH. Stevenson IH. Br J Clin Pharmacol. 1977 Jun;4(3):261-5. doi: 10.1111/j.1365-2125.1977.tb00710.x. Br J Clin Pharmacol. 1977. PMID: 332216 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.
Scotcher D, Jones C, Rostami-Hodjegan A, Galetin A. Scotcher D, et al. Eur J Pharm Sci. 2016 Oct 30;94:59-71. doi: 10.1016/j.ejps.2016.03.018. Epub 2016 Mar 28. Eur J Pharm Sci. 2016. PMID: 27033147 Free PMC article.
Plasma antipyrine half-life can be determined from urine data.
Atiba JO, Taylor G, Pershe RA, Blaschke TF. Atiba JO, et al. Br J Clin Pharmacol. 1987 Jun;23(6):715-9. doi: 10.1111/j.1365-2125.1987.tb03106.x. Br J Clin Pharmacol. 1987. PMID: 2440468 Free PMC article.
Ethical considerations in the conduct of clinical pharmacokinetic studies.
Svensson CK. Svensson CK. Clin Pharmacokinet. 1989 Oct;17(4):217-22. doi: 10.2165/00003088-198917040-00001. Clin Pharmacokinet. 1989. PMID: 2591138 No abstract available.
Effect of acute and chronic exercise on hepatic drug metabolism.
Døssing M. Døssing M. Clin Pharmacokinet. 1985 Sep-Oct;10(5):426-31. doi: 10.2165/00003088-198510050-00004. Clin Pharmacokinet. 1985. PMID: 3899456 Review.

References

1. Br J Pharmacol Chemother. 1967 Feb;29(2):181-93 - PubMed
1. Clin Pharmacol Ther. 1975 Sep;18(3):249-58 - PubMed
1. Clin Pharmacol Ther. 1975 Sep;18(3):259-72 - PubMed
1. Br J Clin Pharmacol. 1976 Apr;3(2):321-5 - PubMed
1. Pharmacology. 1979;18(4):210-23 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources